| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |